相關資料引用 | Rice Kefiran 克菲素® 後生元 & NMN-LIKE® 系列原料

我們的品牌價值是建立在大量科學證據上

相關資料引用

參考文獻

Front Pharmacol. 2021; 12: 666502.
Effects of Kefiran-Feeding on Fecal Cholesterol Excretion, Hepatic Injury and Intestinal Histamine Concentration in Rats. Bioscience and Microflora (2005)
BIOSCIENCE, BIOTECHNOLOGY, AND BIOCHEMISTRY (2019), VOL. 83, NO. 8, 1484–1489 International Journal of Food Microbiology (2008), VOL. 122, Issues 1–2, 29 February 2008, Pages 1-7
J Atheroscler Thromb. 2010 Sep 30;17(9):980-8. doi: 10.5551/jat.4812. Epub 2010 Jun 11.
Kefiran reduces atherosclerosis in rabbits fed a high cholesterol diet. J Atheroscler Thromb. (2010)
Maeda H., Mizumoto H., Suzuki M. and K. Tsuji. 2005. “Effects of Kefiran-Feeding on Fecal Cholesterol Excretion, Hepatic Injury and Intestinal Histamine Concentration in Rats”, Bioscience and Microflora, 24(2), 35-40
Effects of an Exopolysaccharide(Kefiran) from Lactobacillus kefiranofaciens on Blood Glucose in KKAy Mice and Constipation in SD Rats Induced by a Low-Fiber Diet. Bioscience and Microflora (2004)
Maeda H., Zhu X. and T. Mitsuoka. 2004. “Effects of an Exopolysaccharide (Kefiran) from Lactobacillus kefiranofaciens on Blood Glucose in KKAy Mice and Constipation in SD Rats Induced by a Low-Fiber Diet”, Bioscience and Microflora, 23(4), 149-153

內容授權/網站媒體合作

Rice Kefiran 克菲素® 的品牌價值是建立在大量科學證據上

© 本網頁中的公司名、產品名、商標、專利、認證、實驗數據及說明受智慧財產權法保護，未獲授權請勿複製、引用或公開。本網頁內容未經衛福部或FDA證實，不得作為功效宣稱、診斷、治療或預防疾病用途，僅供內部研究評估，請勿做任何商業用途。本網頁內容不代表授權使用本公司或他人之智慧財產權。終端產品標示、文宣、廣告等須遵循衛福部相關規範，使用本網頁內容產生之相關風險或責任應自行承擔。 These statements have not been evaluated by FDA. This product is not intended to diagnose, treat, cure or prevent any disease. Rice Kefiran 克菲素® 益源質® 是註冊商標，擅用必究。